CA2636916A1 - Procedes de traitement de l'hepatite c - Google Patents

Procedes de traitement de l'hepatite c Download PDF

Info

Publication number
CA2636916A1
CA2636916A1 CA002636916A CA2636916A CA2636916A1 CA 2636916 A1 CA2636916 A1 CA 2636916A1 CA 002636916 A CA002636916 A CA 002636916A CA 2636916 A CA2636916 A CA 2636916A CA 2636916 A1 CA2636916 A1 CA 2636916A1
Authority
CA
Canada
Prior art keywords
group
alkyl
optionally substituted
hydrogen
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002636916A
Other languages
English (en)
Inventor
Gary Mitchell Karp
Peter Seongwoo Hwang
James Jan Takasugi
Hongyu Ren
Richard Gerald Wilde
Anthony Allan Turpoff
Alexander Arefolov
Guangming Chen
Jeffrey Allen Campbell
Chunshi Li
Steven Paget
Nanjing Zhang
Xiaoyan Zhang
Jin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PTC Therapeutics Inc
Original Assignee
Ptc Therapeutics, Inc.
Gary Mitchell Karp
Peter Seongwoo Hwang
James Jan Takasugi
Hongyu Ren
Richard Gerald Wilde
Anthony Allan Turpoff
Alexander Arefolov
Guangming Chen
Jeffrey Allen Campbell
Chunshi Li
Steven Paget
Nanjing Zhang
Xiaoyan Zhang
Jin Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/331,180 external-priority patent/US7868037B2/en
Application filed by Ptc Therapeutics, Inc., Gary Mitchell Karp, Peter Seongwoo Hwang, James Jan Takasugi, Hongyu Ren, Richard Gerald Wilde, Anthony Allan Turpoff, Alexander Arefolov, Guangming Chen, Jeffrey Allen Campbell, Chunshi Li, Steven Paget, Nanjing Zhang, Xiaoyan Zhang, Jin Zhu filed Critical Ptc Therapeutics, Inc.
Priority claimed from PCT/US2007/000996 external-priority patent/WO2007084435A2/fr
Publication of CA2636916A1 publication Critical patent/CA2636916A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CA002636916A 2006-01-13 2007-01-16 Procedes de traitement de l'hepatite c Abandoned CA2636916A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US75852706P 2006-01-13 2006-01-13
US11/331,180 US7868037B2 (en) 2004-07-14 2006-01-13 Methods for treating hepatitis C
US60/758,527 2006-01-13
US11/331,180 2006-01-13
US65343507A 2007-01-13 2007-01-13
US11/653,435 2007-01-13
PCT/US2007/000996 WO2007084435A2 (fr) 2006-01-13 2007-01-16 Procedes de traitement de l’hepatite c

Publications (1)

Publication Number Publication Date
CA2636916A1 true CA2636916A1 (fr) 2007-07-26

Family

ID=56290904

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002636916A Abandoned CA2636916A1 (fr) 2006-01-13 2007-01-16 Procedes de traitement de l'hepatite c

Country Status (2)

Country Link
EP (1) EP1979315A2 (fr)
CA (1) CA2636916A1 (fr)

Also Published As

Publication number Publication date
EP1979315A2 (fr) 2008-10-15

Similar Documents

Publication Publication Date Title
US7868037B2 (en) Methods for treating hepatitis C
US7772271B2 (en) Methods for treating hepatitis C
CA2573185A1 (fr) Procedes pour le traitement de l'hepatite c
WO2007084435A2 (fr) Procedes de traitement de l’hepatite c
CA2449180C (fr) Inhibiteurs de polymerase virale
CN102427729B (zh) 丙型肝炎病毒复制的抑制剂
WO2007084413A2 (fr) Procedes de traitement de l’hepatite c
ES2447543T3 (es) Derivados de indol sustituidos y métodos de utilización de los mismos
US7973069B2 (en) Methods for treating hepatitis C
CN102209717B (zh) 治疗丙型肝炎的化合物
TW200924751A (en) 2,3-substituted indole derivatives and methods of use thereof
JP2011503196A (ja) 3−アミノスルホニル置換インドール誘導体およびそれらの使用方法
JP2009523729A (ja) C型肝炎の治療方法
CN101027051A (zh) 治疗丙型肝炎的方法
CA2636916A1 (fr) Procedes de traitement de l'hepatite c
CN101541748A (zh) 治疗丙型肝炎的方法
MX2008009059A (en) Methods for treating hepatitis c
MX2008009061A (es) Metodos para tratar hepatitis c.
TW200831489A (en) Methods for treating hepatitis C
CN101605758A (zh) 治疗丙型肝炎的方法
CN101302182A (zh) 病毒聚合酶抑制剂

Legal Events

Date Code Title Description
FZDE Dead